TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)

NCT01970215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: TA-8995
DRUG: Atorvastatin
DRUG: Rosuvastatin
DRUG: TA-8995 0mg (placebo)
DRUG: Placebo Statin

Sponsor

Xention Ltd